KRRO
Korro Bio, Inc.
10.60$
+0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -80.6% | +54.3% | +17.3% | +32.0% | -11.5% | -53.3% | +102.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +12.3% | -42.7% | -25.3% | +18.5% | -100.0% | – | – | |
| – | -71.0% | +54.3% | +17.3% | +32.0% | -11.5% | -53.3% | – | – | +61.7% | +0.8% | +3.0% | -13.1% | +8.4% | -36.7% | +13.3% | +0.2% | +90.5% | -58.5% | -0.7% | +20.0% | -267.3% | – | – | – | – | -41.4% | – | – | |
| – | – | – | – | – | – | – | +102.5% | -108.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | +12.3% | -42.7% | -25.3% | -41.0% | -159.1% | – | – | |
| – | +19.0% | +8.0% | +31.5% | +15.5% | +16.0% | +28.5% | +14.5% | -10.4% | -19.1% | +8.4% | -3.5% | -12.0% | -9.4% | +43.2% | -10.7% | +6.7% | +10.1% | -12.0% | +26.3% | -6.9% | +6.3% | +16.4% | +6.5% | -34.3% | -20.5% | +17.9% | +4.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -11.1% | -99.9% | -43.8% | +198,720.1% | -2.1% | -2.7% | +95.5% | -31.5% | -11.5% | +5.4% | +30.0% | -6.2% | -12.4% | -5.1% | -4.9% | +20.9% | -12.9% | – | |
| – | +18.3% | +15.1% | +13.9% | +13.1% | +20.8% | +26.4% | +8.2% | -10.1% | -17.1% | +9.4% | -9.2% | -4.1% | -11.4% | +18.7% | -8.4% | +4.0% | +40.4% | -20.2% | +12.5% | -3.5% | +8.7% | +8.9% | +4.0% | -29.1% | -18.7% | +23.7% | -1.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -16.5% | +0.0% | +0.0% | – | – | +26.4% | +18.6% | -9.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -81.6% | +114.3% | -266.7% | – | – | -70.0% | -33.3% | +500.0% | -83.3% | -1,250.0% | – | +242.9% | +12.5% | -125.9% | – | +240.0% | +76.5% | -130.0% | – | – | – | – | – | -85.1% | +13.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.